Top Markets
Coin of the day
Entheon Biomedical Corp. Entheon Biomedical Corp.

Entheon Biomedical Corp.

ENBI
Rang in aandelen #38405
Entheon Biomedical Corp. functions as a biotechnology firm focused on the... Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.
Aandeelprijs
$0.0719818
Laatst gesynchroniseerd: 2026-01-15
Marktkapitalisatie
$997.59K
Verandering (1 dag)
-0.09%
Verandering (1 jaar)
4.67%
Land
CA
Handel Entheon Biomedical Corp. (ENBI)

Categorie

Dividendrendementgeschiedenis voor Entheon Biomedical Corp. (ENBI)
Het dividendrendement (TTM) van Entheon Biomedical Corp. (aandelsymbool: ENBI) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Entheon Biomedical Corp. (ENBI) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten